Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Identification of ataxia telangiectasia heterozygotes, a cancer prone population

Abstract

IN ataxia telangiectasia (AT), an autosomal recessive disease of man with neurological, cutaneous and immunological abnormalities1, cells from homozygotes are sensitive to ionising radiation2 and have a low capacity to repair the resulting DNA damage3. Heterozygotes lack the main clinical features of the syndrome but share with homozygotes a high predisposition to cancer4. One study has demonstrated an increased level of chromosomal abnormalities in some heterozygotes5. Because these heterozygotes represent 1% of the population4 and cannot be diagnosed clinically, their characterisation represents a major challenge in cancer epidemiology. We report here the laboratory identification of a series of obligate heterozygotes for AT, based on the sensitivity of lymphoblastoid cell lines to ionising radiation.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. McFarlin, D. E., Strober, W. & Waldman, T. A. Medicine 51, 280–314 (1972).

    Article  Google Scholar 

  2. Taylor, A. M. R. et al. Nature 258, 427–429 (1975).

    Article  ADS  CAS  Google Scholar 

  3. Paterson, M. C., Smith, B. P., Lohman, P. H. M., Anderson, A. K. & Fishman, L. Nature 260, 444–447 (1976).

    Article  ADS  CAS  Google Scholar 

  4. Swift, M., Sholman, L., Perry, M. & Chase, C. Cancer Res. 36, 209–215 (1976).

    CAS  PubMed  Google Scholar 

  5. Oxford, J. M., Harnden, D. G., Parrington, J. M. & Delhanty, J. D. A. J. med. Genet. 12, 251–262 (1975).

    Article  CAS  Google Scholar 

  6. Moss, D. J. & Pope, J. H. Int. J. Cancer 15, 503–511 (1973).

    Article  Google Scholar 

  7. Moss, D. J. & Pope, J. H. J. gen. Virol. 17, 233–236 (1972).

    Article  ADS  CAS  Google Scholar 

  8. Andrews, A. D., Robbins, J. H., Kraemer, K. H. & Buell, D. N. J. natn. Cancer Inst. 53, 691–693 (1974).

    Article  CAS  Google Scholar 

  9. Patuleia, M. C. & Friend, C. Cancer Res. 27, 726–730 (1967).

    Google Scholar 

  10. Lavin, M. F. & Kidson, C. Nucleic Acids Res. 4, 4015–4022 (1977).

    Article  CAS  Google Scholar 

  11. Lavin, M. F. & Kidson, C. Clin. Immun. Immunopath. (in the press).

  12. Paterson, M. C., Smith, B. P., Knight, P. A. & Anderson, A. K. in Proc. Seventh int. Cong. Photobiol., Rome, 1–12 (1976).

  13. Swift, M. Nature 230, 370–373 (1971).

    Article  ADS  CAS  Google Scholar 

  14. Fujiwara, Y., Tatsumi, M. & Sasaki, M. S. J. molec. Biol. 113, 635–649 (1977).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

address for reprints (C.K.): Queensland Institute of Medical Research, Brisbane 4006, Australia.

Rights and permissions

Reprints and permissions

About this article

Cite this article

CHEN, P., LAVIN, M., KIDSON, C. et al. Identification of ataxia telangiectasia heterozygotes, a cancer prone population. Nature 274, 484–486 (1978). https://doi.org/10.1038/274484a0

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/274484a0

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing